▶ 調査レポート

世界の薬剤・装置コンビネーション製品市場2021年ー2028年:製品種類別(薬剤溶出性ステント(冠状動脈ステント、末梢血管ステント)、輸液ポンプ(埋込型輸液ポンプ、携帯型輸液ポンプ)、光増感剤、整形手術用コンビネーション製品(骨移植片、抗生物質負荷骨セメント)、創傷ケアコンビネーション製品、吸入器(定量吸入器、ドライパウダー吸入器、ネブライザー)、経皮パッチ、その他(眼内インプラント、薬剤溶出性ビーズ))

• 英文タイトル:Drug-device Combination Products Market (Product Type: Drug Eluting Stents [Coronary Stents and Peripheral Vascular Stents], Infusion Pumps [Implantable Infusion Pumps and Ambulatory Infusion Pumps], Photosensitizers, Orthopedic Combination Products [Bone Graft Implants and Antibiotic Loaded Bone Cement], Wound Care Combination Products, Inhalers [Metered Dose Inhalers, Dry Powder Inhalers, and Nebulizers], Transdermal Patches, and Others [Intraocular Implants and Drug Eluting Beads]) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2028

Transparency Market Researchが調査・発行した産業分析レポートです。世界の薬剤・装置コンビネーション製品市場2021年ー2028年:製品種類別(薬剤溶出性ステント(冠状動脈ステント、末梢血管ステント)、輸液ポンプ(埋込型輸液ポンプ、携帯型輸液ポンプ)、光増感剤、整形手術用コンビネーション製品(骨移植片、抗生物質負荷骨セメント)、創傷ケアコンビネーション製品、吸入器(定量吸入器、ドライパウダー吸入器、ネブライザー)、経皮パッチ、その他(眼内インプラント、薬剤溶出性ビーズ)) / Drug-device Combination Products Market (Product Type: Drug Eluting Stents [Coronary Stents and Peripheral Vascular Stents], Infusion Pumps [Implantable Infusion Pumps and Ambulatory Infusion Pumps], Photosensitizers, Orthopedic Combination Products [Bone Graft Implants and Antibiotic Loaded Bone Cement], Wound Care Combination Products, Inhalers [Metered Dose Inhalers, Dry Powder Inhalers, and Nebulizers], Transdermal Patches, and Others [Intraocular Implants and Drug Eluting Beads]) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2028 / MRC2205A095資料のイメージです。• レポートコード:MRC2205A095
• 出版社/出版日:Transparency Market Research / 2022年3月23日
• レポート形態:英文、PDF、117ページ
• 納品方法:Eメール
• 産業分類:医療
• 販売価格(消費税別)
  Single User¥857,660 (USD5,795)▷ お問い合わせ
  Multi User¥1,301,660 (USD8,795)▷ お問い合わせ
  Corporate License¥1,745,660 (USD11,795)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
Transparency Market Research社の本調査資料では、世界の薬剤・装置コンビネーション製品市場について調査し、序論、仮定・調査手法、エグゼクティブサマリー、市場概要、キーインサイト、製品種類別(薬剤溶出性ステント、輸液ポンプ、吸入器、整形手術用コンビネーション製品、創傷ケア用コンビネーション製品)分析、地域別(北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ)分析、競争状況などの項目を掲載しています。
・序論
・仮定・調査手法
・エグゼクティブサマリー
・市場概要
・キーインサイト
・世界の薬剤・装置コンビネーション製品市場規模:製品種類別(薬剤溶出性ステント、輸液ポンプ、吸入器、整形手術用コンビネーション製品、創傷ケア用コンビネーション製品)
・世界の薬剤・装置コンビネーション製品市場規模:地域別(北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ)
・競争状況

Drug-device Combination Products Market – Scope of Report
TMR’s report on the global drug-device combination products market studies past as well as current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2021 to 2028. The report provides revenue of the global drug-device combination products market for the period 2017–2028, considering 2020 as the base year and 2028 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the global drug-device combination products market during the forecast period.

The report has been prepared after an extensive primary and secondary research. Primary research involved bulk of research efforts, wherein analysts carried out interviews with industry leaders and opinion makers. Extensive secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the global drug-device combination products market.

Secondary research also included Internet sources, statistical data from government agencies, websites, company presentations, sales data, and trade associations. Analysts have employed a combination of top-down and bottom-up approaches to study various phenomenon in the global drug-device combination products market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Furthermore, the report sheds light on the changing competitive dynamics in the global drug-device combination products market. These indices serve as valuable tools for existing market players as well as for entities interested in entering the global drug-device combination products market.

The report delves into the competitive landscape of the global drug-device combination products market. Key players operating in the global drug-device combination products market have been identified, and each one of these has been profiled for distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players in the global drug-device combination products market that have been profiled in this report.

Key Questions Answered in Drug-device Combination Products Market Report
What is the scope of growth of product companies in the global drug-device combination products market?
What will be the Y-o-Y growth of the global drug-device combination products market between 2017 and 2028?
What is the influence of changing trends in technologies on the global drug-device combination products market?
Will North America be the most profitable market for drug-device combination products providers?
Which factors are anticipated to hamper the growth of the global drug-device combination products market during the forecast period?
Which are the leading companies in the global drug-device combination products market?

Research Methodology
TMR has utilized a unique research methodology to conduct comprehensive research on the growth of the global drug-device combination products market and arrive at conclusions on its growth prospects. This research methodology is a combination of primary and secondary research, which helps analysts warrant the accuracy and reliability of the drawn conclusions.

Secondary methods referred to by analysts during the production of the global drug-device combination products market report include statistics from company annual reports, SEC filings, company websites, investor presentations, regulatory databases, government publications, and industry white papers. Analysts have also interviewed senior managers, product portfolio managers, CEOs, VPs, and market intelligence managers, who contributed to the production of TMR’s study on the drug-device combination products market as primary methods.

These primary and secondary methods have provided exclusive information during interviews, which serves as a validation from the drug-device combination products market leaders. Access to an extensive internal repository and external proprietary databases enabled this report to address specific details and questions about the global drug-device combination products market with accuracy. The study also uses the top-down approach to assess the revenue for each segment and the bottom-up approach to counter-validate them. This has helped in reaching TMR’s estimates on future prospects of the global drug-device combination products market more reliably and accurately.

レポート目次

1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Drug-device Combination Products Market
4. Market Overview
4.1. Introduction
4.1.1. Product Type Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Drug-device Combination Products Market Analysis and Forecast, 2017-2028
5. Key Insights
5.1. Key Mergers & Acquisitions
5.2. Technological Advancements
5.3. Covid19 Impact Analysis
5.4. Regulatory Scenario by Region/globally
6. Global Drug-device Combination Products Market Analysis and Forecast, by Product Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Product Type, 2017-2028
6.3.1. Drug Eluting Stents
6.3.1.1. Coronary Stents
6.3.1.2. Peripheral Vascular Stents
6.3.2. Infusion Pumps
6.3.2.1. Implantable Infusion Pumps
6.3.2.2. Ambulatory Infusion Pumps
6.3.3. Inhalers
6.3.3.1. Metered Dose Inhalers
6.3.3.2. Dry Powder Inhalers
6.3.3.3. Nebulizers
6.3.4. Orthopedic Combination Products
6.3.4.1. Bone Graft Implants
6.3.4.2. Antibiotic Loaded Bone Cement
6.3.5. Wound Care Combination Products
6.3.6. Photosensitizers
6.3.7. Others
6.4. Market Attractiveness Analysis, by Product Type
7. Global Drug-device Combination Products Market Analysis and Forecast, by Region
7.1. Key Findings
7.2. Market Value Forecast, by Region
7.2.1. North America
7.2.2. Europe
7.2.3. Asia Pacific
7.2.4. Latin America
7.2.5. Middle East & Africa
7.3. Market Attractiveness Analysis, by Region
8. North America Drug-device Combination Products Market Analysis and Forecast
8.1. Introduction
8.1.1. Key Findings
8.2. Market Value Forecast, by Product Type, 2017-2027
8.2.1. Drug Eluting Stents
8.2.1.1. Coronary Stents
8.2.1.2. Peripheral Vascular Stents
8.2.2. Infusion Pumps
8.2.2.1. Implantable Infusion Pumps
8.2.2.2. Ambulatory Infusion Pumps
8.2.3. Inhalers
8.2.3.1. Metered Dose Inhalers
8.2.3.2. Dry Powder Inhalers
8.2.3.3. Nebulizers
8.2.4. Orthopedic Combination Products
8.2.4.1. Bone Graft Implants
8.2.4.2. Antibiotic Loaded Bone Cement
8.2.5. Wound Care Combination Products
8.2.6. Photosensitizers
8.2.7. Others
8.3. Market Value Forecast by Country, 2017-2027
8.3.1. U.S.
8.3.2. Canada
8.4. Market Attractiveness Analysis
8.4.1. By Product Type
8.4.2. By Country
9. Europe Drug-device Combination Products Market Analysis and Forecast
9.1. Introduction
9.1.1. Key Findings
9.2. Market Value Forecast, by Product Type, 2017-2027
9.2.1. Drug Eluting Stents
9.2.1.1. Coronary Stents
9.2.1.2. Peripheral Vascular Stents
9.2.2. Infusion Pumps
9.2.2.1. Implantable Infusion Pumps
9.2.2.2. Ambulatory Infusion Pumps
9.2.3. Inhalers
9.2.3.1. Metered Dose Inhalers
9.2.3.2. Dry Powder Inhalers
9.2.3.3. Nebulizers
9.2.4. Orthopedic Combination Products
9.2.4.1. Bone Graft Implants
9.2.4.2. Antibiotic Loaded Bone Cement
9.2.5. Wound Care Combination Products
9.2.6. Photosensitizers
9.2.7. Others
9.3. Market Value Forecast, by Country/Sub-region, 2017-2027
9.3.1. Germany
9.3.2. U.K.
9.3.3. France
9.3.4. Italy
9.3.5. Spain
9.3.6. Rest of Europe
9.4. Market Attractiveness Analysis
9.4.1. By Product Type
9.4.2. By Country
10. Asia Pacific Drug-device Combination Products Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Product Type, 2017-2027
10.2.1. Drug Eluting Stents
10.2.1.1. Coronary Stents
10.2.1.2. Peripheral Vascular Stents
10.2.2. Infusion Pumps
10.2.2.1. Implantable Infusion Pumps
10.2.2.2. Ambulatory Infusion Pumps
10.2.3. Inhalers
10.2.3.1. Metered Dose Inhalers
10.2.3.2. Dry Powder Inhalers
10.2.3.3. Nebulizers
10.2.4. Orthopedic Combination Products
10.2.4.1. Bone Graft Implants
10.2.4.2. Antibiotic Loaded Bone Cement
10.2.5. Wound Care Combination Products
10.2.6. Photosensitizers
10.2.7. Others
10.3. Market Value Forecast, by Country/Sub-region, 2017-2027
10.3.1. Japan
10.3.2. China
10.3.3. India
10.3.4. Australia & New Zealand
10.3.5. Rest of Asia Pacific
10.4. Market Attractiveness Analysis
10.4.1. By Product Type
10.4.2. By Country
11. Latin America Drug-device Combination Products Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Product Type, 2017-2027
11.2.1. Drug Eluting Stents
11.2.1.1. Coronary Stents
11.2.1.2. Peripheral Vascular Stents
11.2.2. Infusion Pumps
11.2.2.1. Implantable Infusion Pumps
11.2.2.2. Ambulatory Infusion Pumps
11.2.3. Inhalers
11.2.3.1. Metered Dose Inhalers
11.2.3.2. Dry Powder Inhalers
11.2.3.3. Nebulizers
11.2.4. Orthopedic Combination Products
11.2.4.1. Bone Graft Implants
11.2.4.2. Antibiotic Loaded Bone Cement
11.2.5. Wound Care Combination Products
11.2.6. Photosensitizers
11.2.7. Others
11.3. Market Value Forecast, by Country/Sub-region, 2017-2027
11.3.1. Brazil
11.3.2. Mexico
11.3.3. Rest of Latin America
11.4. Market Attractiveness Analysis
11.4.1. By Product Type
11.4.2. By Country
12. Middle East & Africa Drug-device Combination Products Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast by Product Type, 2017-2027
12.2.1. Drug Eluting Stents
12.2.1.1. Coronary Stents
12.2.1.2. Peripheral Vascular Stents
12.2.2. Infusion Pumps
12.2.2.1. Implantable Infusion Pumps
12.2.2.2. Ambulatory Infusion Pumps
12.2.3. Inhalers
12.2.3.1. Metered Dose Inhalers
12.2.3.2. Dry Powder Inhalers
12.2.3.3. Nebulizers
12.2.4. Orthopedic Combination Products
12.2.4.1. Bone Graft Implants
12.2.4.2. Antibiotic Loaded Bone Cement
12.2.5. Wound Care Combination Products
12.2.6. Photosensitizers
12.2.7. Others
12.3. Market Value Forecast, by Country/Sub-region, 2017-2027
12.3.1. GCC Countries
12.3.2. South Africa
12.3.3. Rest of Middle East & Africa
12.4. Market Attractiveness Analysis
12.4.1. By Product Type
12.4.2. By Country
13. Competition Landscape
13.1. Market Player – Competition Matrix (by tier and size of companies)
13.2. Market Share Analysis, by Company, 2020
13.3. Company Profiles
13.3.1. Teva Pharmaceutical Industries Ltd.
13.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
13.3.1.2. Financial Analysis
13.3.1.3. Growth Strategies
13.3.1.4. SWOT Analysis
13.3.2. AbbVie, Inc.
13.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
13.3.2.2. Financial Analysis
13.3.2.3. Growth Strategies
13.3.2.4. SWOT Analysis
13.3.3. Abbott Laboratories
13.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
13.3.3.2. Financial Analysis
13.3.3.3. Growth Strategies
13.3.3.4. SWOT Analysis
13.3.4. Medtronic plc
13.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
13.3.4.2. Financial Analysis
13.3.4.3. Growth Strategies
13.3.4.4. SWOT Analysis
13.3.5. Kaleo, Inc.
13.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
13.3.5.2. Financial Analysis
13.3.5.3. Growth Strategies
13.3.5.4. SWOT Analysis
13.3.6. SINOMED
13.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
13.3.6.2. Financial Analysis
13.3.6.3. Growth Strategies
13.3.6.4. SWOT Analysis
13.3.7. Alcon, Inc.
13.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
13.3.7.2. Financial Analysis
13.3.7.3. Growth Strategies
13.3.7.4. SWOT Analysis
13.3.8. Boston Scientific Corporation
13.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
13.3.8.2. Financial Analysis
13.3.8.3. Growth Strategies
13.3.8.4. SWOT Analysis
13.3.9. Integer Holdings Corporation
13.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
13.3.9.2. Financial Analysis
13.3.9.3. Growth Strategies
13.3.9.4. SWOT Analysis
13.3.10. Teleflex Incorporated
13.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
13.3.10.2. Financial Analysis
13.3.10.3. Growth Strategies
13.3.10.4. SWOT Analysis
13.3.11. Bausch Health Companies Inc
13.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
13.3.11.2. Financial Analysis
13.3.11.3. Growth Strategies
13.3.11.4. SWOT Analysis
13.3.12. Haselmeier GmbH
13.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)
13.3.12.2. Financial Analysis
13.3.12.3. Growth Strategies
13.3.12.4. SWOT Analysis